Annual CFF
$18.15 M
+$8.81 M+94.28%
December 31, 2023
Summary
- As of February 7, 2025, EVGN annual cash flow from financing activities is $18.15 million, with the most recent change of +$8.81 million (+94.28%) on December 31, 2023.
- During the last 3 years, EVGN annual CFF has fallen by -$2.22 million (-10.91%).
- EVGN annual CFF is now -77.14% below its all-time high of $79.41 million, reached on December 31, 2013.
Performance
EVGN Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4.73 M
+$4.88 M+3235.10%
September 1, 2024
Summary
- As of February 7, 2025, EVGN quarterly cash flow from financing activities is $4.73 million, with the most recent change of +$4.88 million (+3235.10%) on September 1, 2024.
- Over the past year, EVGN quarterly CFF has dropped by -$3.06 million (-39.30%).
- EVGN quarterly CFF is now -94.04% below its all-time high of $79.38 million, reached on December 31, 2013.
Performance
EVGN Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$4.07 M
-$3.06 M-42.96%
September 1, 2024
Summary
- As of February 7, 2025, EVGN TTM cash flow from financing activities is $4.07 million, with the most recent change of -$3.06 million (-42.96%) on September 1, 2024.
- Over the past year, EVGN TTM CFF has dropped by -$13.87 million (-77.32%).
- EVGN TTM CFF is now -95.02% below its all-time high of $81.74 million, reached on September 30, 2014.
Performance
EVGN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
EVGN Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +94.3% | -39.3% | -77.3% |
| 3 y3 years | -10.9% | +1429.8% | -56.5% |
| 5 y5 years | +6011.8% | +3004.3% | -58.5% |
EVGN Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.0% | +94.3% | -54.7% | +1382.9% | -86.6% | +194.6% |
| 5 y | 5-year | -40.0% | +95.1% | -82.8% | +1382.9% | -91.7% | +194.6% |
| alltime | all time | -77.1% | >+9999.0% | -94.0% | +905.1% | -95.0% | +956.6% |
Evogene Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.73 M(-3235.1%) | $4.07 M(-43.0%) |
| Jun 2024 | - | -$151.00 K(-58.9%) | $7.13 M(-59.8%) |
| Mar 2024 | - | -$367.00 K(+149.7%) | $17.73 M(-2.3%) |
| Dec 2023 | $18.15 M(+94.3%) | -$147.00 K(-101.9%) | $18.15 M(+1.2%) |
| Sep 2023 | - | $7.80 M(-25.3%) | $17.94 M(-11.7%) |
| Jun 2023 | - | $10.45 M(>+9900.0%) | $20.31 M(+113.9%) |
| Mar 2023 | - | $53.00 K(-114.9%) | $9.50 M(+1.6%) |
| Dec 2022 | $9.34 M(-69.1%) | -$356.00 K(-103.5%) | $9.34 M(-2.6%) |
| Sep 2022 | - | $10.17 M(-2855.6%) | $9.60 M(+594.9%) |
| Jun 2022 | - | -$369.00 K(+269.0%) | $1.38 M(-48.6%) |
| Mar 2022 | - | -$100.00 K(-2.9%) | $2.69 M(-91.1%) |
| Dec 2021 | $30.28 M(+48.6%) | -$103.00 K(-105.3%) | $30.28 M(-26.4%) |
| Sep 2021 | - | $1.95 M(+108.4%) | $41.13 M(-16.0%) |
| Jun 2021 | - | $937.00 K(-96.6%) | $48.97 M(+2.3%) |
| Mar 2021 | - | $27.49 M(+155.8%) | $47.87 M(+134.9%) |
| Dec 2020 | $20.37 M(+118.9%) | $10.75 M(+9.7%) | $20.37 M(+111.1%) |
| Sep 2020 | - | $9.79 M(-6108.0%) | $9.65 M(-1.5%) |
| Jun 2020 | - | -$163.00 K(+8050.0%) | $9.79 M(+4.5%) |
| Mar 2020 | - | -$2000.00(-109.1%) | $9.37 M(+0.7%) |
| Dec 2019 | $9.31 M(+3033.3%) | $22.00 K(-99.8%) | $9.31 M(-1.2%) |
| Sep 2019 | - | $9.94 M(-1790.1%) | $9.42 M(-2082.3%) |
| Jun 2019 | - | -$588.00 K(+790.9%) | -$475.00 K(-327.3%) |
| Mar 2019 | - | -$66.00 K(-150.0%) | $209.00 K(-29.6%) |
| Dec 2018 | $297.00 K | $132.00 K(+180.9%) | $297.00 K(+24.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $47.00 K(-51.0%) | $239.00 K(+70.7%) |
| Jun 2018 | - | $96.00 K(+336.4%) | $140.00 K(-70.9%) |
| Mar 2018 | - | $22.00 K(-70.3%) | $481.00 K(-40.9%) |
| Dec 2017 | $814.00 K(+24.3%) | $74.00 K(-242.3%) | $814.00 K(-31.1%) |
| Sep 2017 | - | -$52.00 K(-111.9%) | $1.18 M(-7.3%) |
| Jun 2017 | - | $437.00 K(+23.1%) | $1.27 M(+25.4%) |
| Mar 2017 | - | $355.00 K(-19.5%) | $1.02 M(+55.1%) |
| Dec 2016 | $655.00 K(+1355.6%) | $441.00 K(+975.6%) | $655.00 K(+159.9%) |
| Sep 2016 | - | $41.00 K(-77.1%) | $252.00 K(+358.2%) |
| Jun 2016 | - | $179.00 K(-3083.3%) | $55.00 K(-72.2%) |
| Mar 2016 | - | -$6000.00(-115.8%) | $198.00 K(+340.0%) |
| Dec 2015 | $45.00 K(-98.3%) | $38.00 K(-124.4%) | $45.00 K(-85.7%) |
| Sep 2015 | - | -$156.00 K(-148.4%) | $314.00 K(-85.2%) |
| Jun 2015 | - | $322.00 K(-302.5%) | $2.12 M(+1.3%) |
| Mar 2015 | - | -$159.00 K(-151.8%) | $2.09 M(-21.7%) |
| Dec 2014 | $2.67 M(-96.6%) | $307.00 K(-81.3%) | $2.67 M(-96.7%) |
| Sep 2014 | - | $1.65 M(+459.5%) | $81.74 M(+2.2%) |
| Jun 2014 | - | $294.00 K(-30.0%) | $79.94 M(+0.5%) |
| Mar 2014 | - | $420.00 K(-99.5%) | $79.57 M(+0.2%) |
| Dec 2013 | $79.41 M(+7047.4%) | $79.38 M(<-9900.0%) | $79.41 M(>+9900.0%) |
| Sep 2013 | - | -$152.00 K(+81.0%) | $26.00 K(-85.4%) |
| Jun 2013 | - | -$84.00 K(-132.1%) | $178.00 K(-32.1%) |
| Mar 2013 | - | $262.00 K | $262.00 K |
| Dec 2012 | $1.11 M(-95.7%) | - | - |
| Dec 2011 | $25.58 M | - | - |
FAQ
- What is Evogene annual cash flow from financing activities?
- What is the all time high annual CFF for Evogene?
- What is Evogene annual CFF year-on-year change?
- What is Evogene quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Evogene?
- What is Evogene quarterly CFF year-on-year change?
- What is Evogene TTM cash flow from financing activities?
- What is the all time high TTM CFF for Evogene?
- What is Evogene TTM CFF year-on-year change?
What is Evogene annual cash flow from financing activities?
The current annual CFF of EVGN is $18.15 M
What is the all time high annual CFF for Evogene?
Evogene all-time high annual cash flow from financing activities is $79.41 M
What is Evogene annual CFF year-on-year change?
Over the past year, EVGN annual cash flow from financing activities has changed by +$8.81 M (+94.28%)
What is Evogene quarterly cash flow from financing activities?
The current quarterly CFF of EVGN is $4.73 M
What is the all time high quarterly CFF for Evogene?
Evogene all-time high quarterly cash flow from financing activities is $79.38 M
What is Evogene quarterly CFF year-on-year change?
Over the past year, EVGN quarterly cash flow from financing activities has changed by -$3.06 M (-39.30%)
What is Evogene TTM cash flow from financing activities?
The current TTM CFF of EVGN is $4.07 M
What is the all time high TTM CFF for Evogene?
Evogene all-time high TTM cash flow from financing activities is $81.74 M
What is Evogene TTM CFF year-on-year change?
Over the past year, EVGN TTM cash flow from financing activities has changed by -$13.87 M (-77.32%)